Precigen
PGENPrecigen, Inc (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies enginee …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Precigen
Subscribe RSSDate | Type | Insider | Position | Ø-Price | Volume |
---|---|---|---|---|---|
12/28/2023 | Sell | Kindler, Jeffrey B. | Director | $1.4 | $136,327 |
12/28/2023 | Buy | Kirk, Randal J. | Director | $1.4 | $136,327 |
9/22/2023 | Buy | Mitchell, Dean J. | Director | $1.4 | $35,250 |
8/25/2023 | Sell | Sabzevari, Helen | President and CEO | $1.5 | $117,763 |
8/24/2023 | Sell | Thomasian, Harry Jr. | Chief Financial Officer | $1.6 | $14,834 |